Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites

Table 2 Outcomes of symptoms in the four groups of patients, n (%)

Symptoms	Group A, n = 183	Group B, n = 217	χ2	P value	Group C, n = 328	Group D, n = 135	χ2	P value
First week of ascites	172 (93.98)	156 (71.88)		0.032	311 (94.81)	82 (60.74)		0.027
Hepatic function compromise	43 (23.49)	146 (67.28)	2.072	0.024	47 (14.32)	96 (71.11)	3.043	0.019
Recurrence of ascites	40 (21.85)	173 (79.72)		0.016	64 (19.51)	119 (88.14)		0.012
Hepatic dysfunction	33 (18.03)	154 (70.96)		0.007	51 (15.54)	107 (79.25)		0.004
Others	7 (3.82)	19 (8.75)		0.025	13 (3.96)	12 (8.88)		0.019
Ascites recurrence times	48	326		0.000	103	202		0.001

The symptoms of ascites in four groups disappeared or were relieved within the first week without paracentesis. The probability of total hepatic impairment and recurrent ascites was significantly different between the groups.